Publications

Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signature.

Habgood-Coote, D; Wilson, C; Shimizu, C; Barendregt, AM; Philipsen, R; Galassini, R; Calle, IR; Workman, L; Agyeman, PK A; Ferwerda, G; Anderson, ST; Van den Berg, JM; Emonts, M; Carrol, ED; Fink, CG; De Groot, R; HIBBERD, ML; Kanegaye, J; Nicol, MP; Paulus, S; Pollard, AJ; Salas, A; SECKA, F; Schlapbach, LJ; Tremoulet, AH; ... Kaforou, M.

2023

Med (New York, N.Y.), (2023).4 9 10.1016/j.medj.2023.06.007.

Serological evaluation of risk factors for exposure to malaria in a pre-elimination setting in Malaysian Borneo.

BYRNE, I; William, T; Chua, TH; PATTERSON, C; Hall, T; Tan, M; Chitnis, C; Adams, J; Singh, SK; GRIGNARD, L; TETTEH, KK A; Fornace, KM; DRAKELEY, CJ;

2023

Scientific reports, (2023).13 1 10.1038/s41598-023-39670-w.

Plasmodium berghei oocysts possess fatty acid synthesis and scavenging routes.

Saeed, S; TREMP, AZ; DESSENS, JT;

2023

Scientific reports, (2023).13 1 10.1038/s41598-023-39708-z.

The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen.

MANNO, D; PATTERSON, C; DRAMMEH, A; TETTEH, K; KROMA, MT; Otieno, GT; Lawal, BJ; SOREMEKUN, S; AYIEKO, P; Gaddah, A; Kamara, AB; Baiden, F; AFOLABI, MO; TINDANBIL, D; Owusu-Kyei, K; Ishola, D; Deen, GF; Keshinro, B; Njie, Y; Samai, M; Lowe, B; Robinson, C; Leigh, B; DRAKELEY, C; GREENWOOD, B; ... WATSON-JONES, D.

2023

Vaccines, (2023).11 8 10.3390/vaccines11081317.

Effects of next-generation, dual-active-ingredient, long-lasting insecticidal net deployment on insecticide resistance in malaria vectors in Tanzania: an analysis of a 3-year, cluster-randomised controlled trial.

Messenger, LA; MATOWO, NS; Cross, CL; Jumanne, M; Portwood, NM; MARTIN, J; Lukole, E; Mallya, E; Mosha, JF; Kaaya, R; Moshi, O; PELLOQUIN, B; Fullerton, K; Manjurano, A; Mosha, FW; Walker, T; ROWLAND, M; Kulkarni, MA; PROTOPOPOFF, N;

2023

The Lancet. Planetary health, (2023).7 8 10.1016/S2542-5196(23)00137-7.

Sequential roles for red blood cell binding proteins enable phased commitment to invasion for malaria parasites.

Hart, MN; Mohring, F; DONVITO, SM; THOMAS, JA; Muller-Sienerth, N; Wright, GJ; Knuepfer, E; Saibil, HR; MOON, RW;

2023

Nature communications, (2023).14 1 10.1038/s41467-023-40357-z.

Defining operational research priorities to improve malaria control and elimination in sub-Saharan Africa: results from a country-driven research prioritization setting process.

Tine, R; Herrera, S; Badji, MA; Daniels, K; Ndiaye, P; Smith Gueye, C; Tairou, F; Slutsker, L; Hwang, J; Ansah, E; Littrell, M; Malaria Operational Research Prioritization Partne,;

2023

Malaria journal, (2023).22 1 10.1186/s12936-023-04654-8.

PermaNet Dual, a new deltamethrin-chlorfenapyr mixture net, shows improved efficacy against pyrethroid-resistant Anopheles gambiae sensu lato in southern Benin.

SYME, T; N'dombidjé, B; Gbegbo, M; Todjinou, D; Ariori, V; De Vos, P; Pigeon, O; NGUFOR, C;

2023

Scientific reports, (2023).13 1 10.1038/s41598-023-39140-3.

Field performance of three mosquito collection methods for assessing the entomological efficacy of dual-active ingredient long-lasting insecticidal nets.

Yovogan, B; Adoha, CJ; Akinro, B; Accrombessi, M; Dangbénon, E; Sidick, A; Ossè, R; Padonou, GG; Messenger, LA; Fassinou, A; Sagbohan, HW; Agbangla, C; Djènontin, A; Odjo, EM; NGUFOR, C; COOK, J; PROTOPOPOFF, N; SOVI, A; Akogbéto, MC;

2023

Scientific reports, (2023).13 1 10.1038/s41598-023-39558-9.

Macrocyclic Peptidomimetic Plasmepsin X Inhibitors with Potent In Vitro and In Vivo Antimalarial Activity.

Kovada, V; Withers-Martinez, C; Bobrovs, R; Ce Rule, HN; Liepins, E; Grinberga, S; Hackett, F; Collins, CR; Kreicberga, A; Jiménez-Díaz, MB; Angulo-Barturen, I; Rasina, D; Suna, E; Jaudzems, K; BLACKMAN, MJ; Jirgensons, A;

2023

Journal of medicinal chemistry, (2023).66 15 10.1021/acs.jmedchem.3c00812.